CHRS
Coherus BioSciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$219.03M
P/E Ratio
—
EPS
$-1.42
Beta
0.96
52W High
$2.62
52W Low
$0.71
50-Day MA
$1.68
200-Day MA
$1.60
Dividend Yield
—
Profit Margin
397.30%
Forward P/E
41.15
PEG Ratio
0.00
About Coherus BioSciences Inc
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | $46.88M |
| Gross Profit (TTM) | $31.91M |
| EBITDA | $-163.39M |
| Operating Margin | -293.70% |
| Return on Equity | 33.10% |
| Return on Assets | -32.80% |
| Revenue/Share (TTM) | $0.38 |
| Book Value | $0.51 |
| Price-to-Book | 2.79 |
| Price-to-Sales (TTM) | 4.67 |
| EV/Revenue | 1.962 |
| EV/EBITDA | 1.28 |
| Quarterly Earnings Growth (YoY) | -75.50% |
| Quarterly Revenue Growth (YoY) | 62.00% |
| Shares Outstanding | $154.25M |
| Float | $132.53M |
| % Insiders | 18.64% |
| % Institutions | 38.56% |
Historical Volatility
HV 10-Day
68.32%
HV 20-Day
58.46%
HV 30-Day
71.93%
HV 60-Day
66.98%
HV Rank
36.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($7.80 target)
1
Strong Buy4
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026